{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T01:35:28Z","timestamp":1794533728423,"version":"4.9.1"},"reference-count":107,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.annder.2026.103503","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T15:59:42Z","timestamp":1776873582000},"page":"103503","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Cutaneous leishmaniasis: 2026 guidelines for diagnosis and treatment"],"prefix":"10.1016","volume":"153","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3695-6824","authenticated-orcid":false,"given":"R.","family":"Blaizot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Pasquier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1495-3494","authenticated-orcid":false,"given":"P.","family":"Picherit-Steinbrucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Demar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8681-3445","authenticated-orcid":false,"given":"C.","family":"Rouges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Dahane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Ravel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Lachaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Buffet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Melenotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2026.103503_b0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010745","article-title":"Leishmaniasis epidemiology in endemic areas of metropolitan France and its overseas territories from 1998 to 2020","volume":"16","author":"Pasquier","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.annder.2026.103503_b0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.annder.2026.103503_b0015","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1111\/ijd.14625","article-title":"American cutaneous leishmaniasis in French Guiana: an epidemiological update and study of environmental risk factors","volume":"58","author":"Loiseau","year":"2019","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.annder.2026.103503_b0020","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s41182-017-0045-x","article-title":"Cutaneous leishmaniasis in French Guiana: revising epidemiology with PCR-RFLP","volume":"45","author":"Simon","year":"2017","journal-title":"Trop Med Health"},{"key":"10.1016\/j.annder.2026.103503_b0025","doi-asserted-by":"crossref","first-page":"190","DOI":"10.7705\/biomedica.v20i3.1060","article-title":"Efectos de la temperatura y la dieta sobre el crecimiento y la longevidad de flebotom\u00edneos (Diptera: Psychodidae)","volume":"20","author":"Guzm\u00e1n","year":"2000","journal-title":"Biom\u00e9dica"},{"key":"10.1016\/j.annder.2026.103503_b0030","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1186\/s13071-024-06381-8","article-title":"Cutaneous leishmaniasis in sub-Saharan Africa: a systematic review of Leishmania species, vectors and reservoirs","volume":"17","author":"Blaizot","year":"2024","journal-title":"Parasit Vectors"},{"key":"10.1016\/j.annder.2026.103503_b0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009863","article-title":"Clinical diversity and treatment results in Tegumentary Leishmaniasis: a European clinical report in 459 patients","volume":"15","author":"Guery","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.annder.2026.103503_b0040","doi-asserted-by":"crossref","first-page":"377","DOI":"10.4081\/gh.2014.27","article-title":"Risk map for cutaneous leishmaniasis in Ethiopia based on environmental factors as revealed by geographical information systems and statistics","volume":"8","author":"Seid","year":"2014","journal-title":"Geospat Health"},{"key":"10.1016\/j.annder.2026.103503_b0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004545","article-title":"Old World Cutaneous Leishmaniasis and Refugee crises in the Middle East and North Africa","volume":"10","author":"Du","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.annder.2026.103503_b0050","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3201\/eid0906.030026","article-title":"Anthroponotic Cutaneous Leishmaniasis, Kabul","volume":"9","author":"Reithinger","year":"2003","journal-title":"Afghanistan Emerg Infect Dis"},{"key":"10.1016\/j.annder.2026.103503_b0055","article-title":"A climatic suitability indicator to support Leishmania infantum surveillance in Europe: a modelling study","volume":"43","author":"Carvalho","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.annder.2026.103503_b0060","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taae051","article-title":"Surge in imported cutaneous leishmaniasis cases from Mexico in 2023: a case series","volume":"31","author":"Equihua Martinez","year":"2024","journal-title":"J Travel Med"},{"key":"10.1016\/j.annder.2026.103503_b0065","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0733-8635(18)30058-5","article-title":"Epidemiology of the leishmaniases","volume":"13","author":"Magill","year":"1995","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.annder.2026.103503_b0070","series-title":"Epidemiological trends of Cutaneous Leishmaniasis in French Guiana: a 5-year retrospective study","author":"Blaizot","year":"2022"},{"key":"10.1016\/j.annder.2026.103503_b0075","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/ced\/llad146","article-title":"Using pentamidine to treat cutaneous leishmaniasis in children: a 10-year study in French Guiana","volume":"48","author":"Heleine","year":"2023","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.annder.2026.103503_b0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008380","article-title":"Leishmania naiffi and lainsoni in French Guiana: Clinical features and phylogenetic variability","volume":"14","author":"Ducharme","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.annder.2026.103503_b0085","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1051\/parasite\/2014011","article-title":"Leishmania (Leishmania) martiniquensis n. sp. (Kinetoplastida: Trypanosomatidae), description of the parasite responsible for cutaneous leishmaniasis in Martinique Island (French West Indies)","volume":"21","author":"Desbois","year":"2014","journal-title":"Parasite Paris Fr"},{"key":"10.1016\/j.annder.2026.103503_b0090","doi-asserted-by":"crossref","first-page":"317","DOI":"10.4269\/ajtmh.14-0205","article-title":"First case of visceral leishmaniasis caused by Leishmania martiniquensis","volume":"92","author":"Liautaud","year":"2015","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.annder.2026.103503_b0095","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1051\/parasite\/2024045","article-title":"Phlebotomine sand fly distribution and abundance in France: a systematic review","volume":"31","author":"Prudhomme","year":"2024","journal-title":"Parasite"},{"key":"10.1016\/j.annder.2026.103503_b0100","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S1473-3099(16)30195-5","article-title":"Global burden of cutaneous leishmaniasis","volume":"16","author":"Reithinger","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.annder.2026.103503_b0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0011415","article-title":"Updated estimation of cutaneous leishmaniasis incubation period in French Guiana","volume":"17","author":"Blaizot","year":"2023","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.annder.2026.103503_b0110","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1365-4632.2007.03154.x","article-title":"Clinical manifestations and classification of Old World cutaneous leishmaniasis","volume":"46","author":"Akilov","year":"2007","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.annder.2026.103503_b0115","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.4269\/ajtmh.20-0439","article-title":"Assessment of Incubation Period of Cutaneous Leishmaniasis due to Leishmania major in Tunisia","volume":"103","author":"Aoun","year":"2020","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.annder.2026.103503_b0120","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/tmi.12928","article-title":"Clinical features and treatment response of cutaneous leishmaniasis in North-West Ethiopia","volume":"22","author":"Fikre","year":"2017","journal-title":"Trop Med Int Health TM IH"},{"key":"10.1016\/j.annder.2026.103503_b0125","doi-asserted-by":"crossref","first-page":"704","DOI":"10.4269\/ajtmh.2009.80.704","article-title":"Leishmaniases in Bolivia: comprehensive review and current status","volume":"80","author":"Garc\u00eda","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.annder.2026.103503_b0130","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1590\/s1678-9946202365047","article-title":"Factors associated with mucosal involvement in tegumentary leishmaniasis: a nation-based study using surveillance data from Brazil","volume":"65","author":"Monachesi","year":"2023","journal-title":"Rev Inst Med Trop S\u00e3o Paulo"},{"key":"10.1016\/j.annder.2026.103503_b0135","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.inhe.2012.06.004","article-title":"Local or systemic treatment for New World cutaneous leishmaniasis? Re-evaluating the evidence for the risk of mucosal leishmaniasis","volume":"4","author":"Blum","year":"2012","journal-title":"Int Health"},{"key":"10.1016\/j.annder.2026.103503_b0140","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1590\/abd1806-4841.20198775","article-title":"Disseminated leishmaniasis: clinical, pathogenic, and therapeutic aspects","volume":"94","author":"Machado","year":"2019","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.annder.2026.103503_b0145","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1128\/JCM.02064-12","article-title":"Association between an emerging disseminated form of leishmaniasis and Leishmania (Viannia) braziliensis strain polymorphisms","volume":"50","author":"Queiroz","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.annder.2026.103503_b0150","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1080\/00034983.1969.11686649","article-title":"Studies on leishmaniasis in Ethiopia. I. Preliminary investigations into the epidemiology of cutaneous leishmaniasis in the highlands","volume":"63","author":"Lemma","year":"1969","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.annder.2026.103503_b0155","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1590\/s1678-9946201860005","article-title":"First case report of atypical disseminated cutaneous leishmaniasis in an opium abuser in Iran","volume":"60","author":"Hashemi","year":"2018","journal-title":"Rev Inst Med Trop S\u00e3o Paulo"},{"key":"10.1016\/j.annder.2026.103503_b0160","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/j.1365-4632.2008.03804.x","article-title":"Diffuse cutaneous leishmaniasis associated with the immune reconstitution inflammatory syndrome","volume":"47","author":"Sinha","year":"2008","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.annder.2026.103503_b0165","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/j.1365-2133.2007.08157.x","article-title":"Post-kala-azar dermal leishmaniasis as an immune reconstitution inflammatory syndrome in a patient with acquired immune deficiency syndrome","volume":"157","author":"Antinori","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2026.103503_b0170","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1600-0560.2006.00532.x","article-title":"Reactivation of dormant cutaneous Leishmania infection in a kidney transplant patient","volume":"33","author":"Mirzabeigi","year":"2006","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.annder.2026.103503_b0175","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1086\/382135","article-title":"Persistence of leishmania parasites in scars after clinical cure of American cutaneous leishmaniasis: is there a sterile cure?","volume":"189","author":"Mendon\u00e7a","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.annder.2026.103503_b0180","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/j.1365-2133.2004.06226.x","article-title":"Comparative study of cutaneous leishmaniasis in human immunodeficiency virus (HIV)-infected patients and non-HIV-infected patients in French Guiana","volume":"151","author":"Couppi\u00e9","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2026.103503_b0185","first-page":"147","article-title":"Leishmaniasis\u2013HIV coinfection: current challenges","volume":"8","author":"Lindoso","year":"2016","journal-title":"HIVAIDS Auckl NZ"},{"key":"10.1016\/j.annder.2026.103503_b0190","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1365-2133.2008.08908.x","article-title":"Unusual manifestations of tegumentary leishmaniasis in AIDS patients from the New World","volume":"160","author":"Lindoso","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2026.103503_b0195","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1086\/497338","article-title":"Tegumentary leishmaniasis as a manifestation of immune reconstitution inflammatory syndrome in 2 patients with AIDS","volume":"192","author":"Posada-Vergara","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.annder.2026.103503_b0200","article-title":"Cutaneous leishmaniasis as immune reconstitution syndrome: a clinical and histopathological case series","author":"Luce","year":"2024","journal-title":"J Eur Acad Dermatol Venereol JEADV"},{"key":"10.1016\/j.annder.2026.103503_b0205","doi-asserted-by":"crossref","first-page":"270","DOI":"10.4269\/ajtmh.2006.75.270","article-title":"Pseudomonas aeruginosa otochondritis complicating localized cutaneous leishmaniasis: prevention of mutilation by early antibiotic therapy","volume":"75","author":"Van Der Vliet","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.annder.2026.103503_b0210","unstructured":"Pan American Health Organization. Leishmaniasis in the Americas: Treatment Recommandations Meeting on Advancing Economics for the Prevention and Control of Noncommunicable Diseases in the Americas (Washington, D.C., 31 August - 1 September 2016). Washington, D.C.: PAHO; 2018. n.d."},{"key":"10.1016\/j.annder.2026.103503_b0215","doi-asserted-by":"crossref","first-page":"e02218","DOI":"10.1128\/JCM.02218-20","article-title":"Validation of Swab sampling and SYBR green-based real-time PCR for the diagnosis of Cutaneous Leishmaniasis in French Guiana","volume":"59","author":"Blaizot","year":"2021","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.annder.2026.103503_b0220","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1128\/JCM.00845-17","article-title":"Identification of Leishmania by Matrix-Assisted Laser Desorption Ionization-Time of Flight (MALDI-TOF) mass spectrometry using a free web-based application and a dedicated mass-spectral library","volume":"55","author":"Lachaud","year":"2017","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.annder.2026.103503_b0225","doi-asserted-by":"crossref","first-page":"e2841","DOI":"10.1371\/journal.pntd.0002841","article-title":"Easy identification of leishmania species by mass spectrometry","volume":"8","author":"Mouri","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.annder.2026.103503_b0230","doi-asserted-by":"crossref","first-page":"5249","DOI":"10.1128\/JCM.42.11.5249-5255.2004","article-title":"Quantification of Leishmania infantum DNA by a real-time PCR assay with high sensitivity","volume":"42","author":"Mary","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.annder.2026.103503_b0235","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1128\/JCM.02555-06","article-title":"Detection and identification of Leishmania species from clinical specimens by using a real-time PCR assay and sequencing of the cytochrome B gene","volume":"45","author":"Foulet","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.annder.2026.103503_b0240","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1128\/JCM.02936-13","article-title":"Evaluation of four single-locus markers for Leishmania species discrimination by sequencing","volume":"52","author":"Van der Auwera","year":"2014","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.annder.2026.103503_b0245","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.4269\/ajtmh.19-0591","article-title":"Immunoblot for the Diagnosis of Cutaneous Leishmaniasis in French Guiana","volume":"104","author":"Menu","year":"2021","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.annder.2026.103503_b0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009531","article-title":"A review of the leishmanin skin test: a neglected test for a neglected disease","volume":"15","author":"Carstens-Kass","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"issue":"40","key":"10.1016\/j.annder.2026.103503_b0255","first-page":"173","article-title":"Therapy of leishmaniasis in France: consensus on proposed guidelines","volume":"2011","author":"Buffet","year":"1983","journal-title":"Presse Medicale Paris Fr"},{"key":"10.1016\/j.annder.2026.103503_b0260","doi-asserted-by":"crossref","first-page":"e202","DOI":"10.1093\/cid\/ciw670","article-title":"Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)","volume":"63","author":"Aronson","year":"2016","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.annder.2026.103503_b0265","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4269\/ajtmh.2007.76.48","article-title":"Healing of Old World cutaneous leishmaniasis in travelers treated with fluconazole: drug effect or spontaneous evolution?","volume":"76","author":"Morizot","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.annder.2026.103503_b0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004017","article-title":"Spatio-temporal Genetic Structuring of Leishmania major in Tunisia by Microsatellite Analysis","volume":"9","author":"Harrabi","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.annder.2026.103503_b0275","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0738-081X(96)00058-2","article-title":"Cutaneous leishmaniasis: clinical aspect","volume":"14","author":"Dowlati","year":"1996","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.annder.2026.103503_b0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0149697","article-title":"The cure rate after placebo or no therapy in American cutaneous leishmaniasis: a systematic review and meta-analysis","volume":"11","author":"Cota","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.annder.2026.103503_b0285","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.clindermatol.2006.05.008","article-title":"Cutaneous leishmaniasis","volume":"25","author":"Bailey","year":"2007","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.annder.2026.103503_b0290","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1186\/s12879-017-2658-4","article-title":"Clinical and laboratory profiles of patients with early spontaneous healing in cutaneous localized leishmaniasis: a historical cohort study","volume":"17","author":"Oliveira-Ribeiro","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.annder.2026.103503_b0295","doi-asserted-by":"crossref","first-page":"642","DOI":"10.3201\/eid2504.180239","article-title":"Mucosal leishmaniasis in travelers with leishmania braziliensis complex returning to Israel","volume":"25","author":"Solomon","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.annder.2026.103503_b0300","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1056\/NEJMoa1202657","article-title":"Topical paromomycin with or without gentamicin for cutaneous leishmaniasis","volume":"368","author":"Ben Salah","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annder.2026.103503_b0305","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/0035-9203(94)90308-5","article-title":"Treatment of \u201cOld World\u201d cutaneous leishmaniasis with aminosidine ointment: results of an open study in London","volume":"88","author":"Bryceson","year":"1994","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.annder.2026.103503_b0310","doi-asserted-by":"crossref","first-page":"466","DOI":"10.4269\/ajtmh.2001.65.466","article-title":"Randomized, controlled, double-blind trial of topical treatment of cutaneous leishmaniasis with paromomycin plus methylbenzethonium chloride ointment in Guatemala","volume":"65","author":"Arana","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.annder.2026.103503_b0315","doi-asserted-by":"crossref","first-page":"e2749","DOI":"10.1371\/journal.pntd.0002749","article-title":"Parasite load decrease during application of a safe and easily applied antileishmanial aminoglycoside cream","volume":"8","author":"Ben Salah","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.annder.2026.103503_b0320","doi-asserted-by":"crossref","first-page":"e432","DOI":"10.1371\/journal.pntd.0000432","article-title":"WR279,396, a third generation aminoglycoside ointment for the treatment of Leishmania major cutaneous leishmaniasis: a phase 2, randomized, double blind, placebo controlled study","volume":"3","author":"Ben Salah","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.annder.2026.103503_b0325","doi-asserted-by":"crossref","first-page":"557","DOI":"10.4269\/ajtmh.12-0736","article-title":"Randomized, double-blinded, phase 2 trial of WR 279,396 (paromomycin and gentamicin) for cutaneous leishmaniasis in Panama","volume":"89","author":"Sosa","year":"2013","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.annder.2026.103503_b0330","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0011492","article-title":"Self-application of aminoglycoside-based creams to treat cutaneous leishmaniasis in travelers","volume":"17","author":"Mouri","year":"2023","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.annder.2026.103503_b0335","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0293529","article-title":"Treatment outcomes of cutaneous leishmaniasis due to Leishmania aethiopica: a systematic review and meta-analysis","volume":"18","author":"Alemu","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.annder.2026.103503_b0340","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1093\/cid\/ciy619","article-title":"Topical 15% paromomycin-aquaphilic for bolivian leishmania braziliensis cutaneous leishmaniasis: a randomized, placebo-controlled trial","volume":"68","author":"Soto","year":"2019","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.annder.2026.103503_b0345","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/s12879-016-1663-3","article-title":"Efficacy of cryotherapy for the treatment of cutaneous leishmaniasis: meta-analyses of clinical trials","volume":"16","author":"L\u00f3pez-Carvajal","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.annder.2026.103503_b0350","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-4632.2004.02002.x","article-title":"Comparative study of the efficacy of combined cryotherapy and intralesional meglumine antimoniate (Glucantime) vs. cryotherapy and intralesional meglumine antimoniate (Glucantime) alone for the treatment of cutaneous leishmaniasis","volume":"43","author":"Asilian","year":"2004","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.annder.2026.103503_b0355","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1179\/000349803225001373","article-title":"The efficacy of treatment with intralesional meglumine antimoniate alone, compared with that of cryotherapy combined with the meglumine antimoniate or intralesional sodium stibogluconate, in the treatment of cutaneous leishmaniasis","volume":"97","author":"Asilian","year":"2003","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.annder.2026.103503_b0360","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1645\/GE-185R","article-title":"Clinical features, epidemiology, and efficacy and safety of intralesional antimony treatment of cutaneous leishmaniasis: recent experience in Turkey","volume":"90","author":"Uzun","year":"2004","journal-title":"J Parasitol"},{"key":"10.1016\/j.annder.2026.103503_b0365","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1365-4362.1996.tb03669.x","article-title":"Cutaneous leishmaniasis: schedules for intralesional treatment with sodium stibogluconate","volume":"35","author":"Tallab","year":"1996","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.annder.2026.103503_b0370","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1111\/j.1468-3083.2009.03157.x","article-title":"Treatment of cutaneous leishmaniasis with intralesional sodium stibogluconate","volume":"23","author":"Solomon","year":"2009","journal-title":"J Eur Acad Dermatol Venereol JEADV"},{"key":"10.1016\/j.annder.2026.103503_b0375","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/cid\/ciad253","article-title":"A Randomized, Controlled, Noninferiority, Multicenter Trial of Systemic vs Intralesional Treatment with Meglumine Antimoniate for Cutaneous Leishmaniasis in Brazil","volume":"77","author":"Lyra","year":"2023","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.annder.2026.103503_b0380","doi-asserted-by":"crossref","first-page":"265","DOI":"10.4103\/2229-5151.170849","article-title":"Lip leishmaniasis: Clinical characteristics of 621 patients","volume":"5","author":"Ye\u015filova","year":"2015","journal-title":"Int J Crit Illn Inj Sci"},{"key":"10.1016\/j.annder.2026.103503_b0385","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1111\/jdv.12580","article-title":"Mucosal leishmaniasis of the lip: an emerging clinical form in Tunisia","volume":"29","author":"Hammami-Ghorbel","year":"2015","journal-title":"J Eur Acad Dermatol Venereol JEADV"},{"key":"10.1016\/j.annder.2026.103503_b0390","doi-asserted-by":"crossref","DOI":"10.4178\/epih.e2019011","article-title":"Efficacy of miltefosine compared with glucantime for the treatment of cutaneous leishmaniasis: a systematic review and meta-analysis","volume":"41","author":"Iranpour","year":"2019","journal-title":"Epidemiol Health"},{"key":"10.1016\/j.annder.2026.103503_b0395","doi-asserted-by":"crossref","first-page":"e2457","DOI":"10.1093\/cid\/ciaa1238","article-title":"Efficacy and Tolerability of Miltefosine in the Treatment of Cutaneous Leishmaniasis","volume":"73","author":"Ware","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.annder.2026.103503_b0400","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/jvc2.400","article-title":"Use of miltefosine in the treatment of cutaneous leishmaniasis in French Guiana","volume":"3","author":"Oliveira","year":"2024","journal-title":"JEADV Clin Pract"},{"key":"10.1016\/j.annder.2026.103503_b0405","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1086\/383321","article-title":"Miltefosine for new world cutaneous leishmaniasis","volume":"38","author":"Soto","year":"2004","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.annder.2026.103503_b0410","doi-asserted-by":"crossref","first-page":"210","DOI":"10.4269\/ajtmh.2008.78.210","article-title":"Efficacy of miltefosine for Bolivian cutaneous leishmaniasis","volume":"78","author":"Soto","year":"2008","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.annder.2026.103503_b0415","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000912","article-title":"Miltefosine in the treatment of cutaneous leishmaniasis caused by leishmania braziliensis in Brazil: a randomized and controlled trial","volume":"4","author":"Machado","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.annder.2026.103503_b0420","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.actatropica.2007.05.005","article-title":"Comparison of miltefosine and meglumine antimoniate for the treatment of zoonotic cutaneous leishmaniasis (ZCL) by a randomized clinical trial in Iran","volume":"103","author":"Mohebali","year":"2007","journal-title":"Acta Trop"},{"key":"10.1016\/j.annder.2026.103503_b0425","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1086\/648726","article-title":"Miltefosine treatment of Leishmania major infection: an observational study involving Dutch military personnel returning from northern Afghanistan","volume":"50","author":"van Thiel","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.annder.2026.103503_b0430","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.actatropica.2018.03.016","article-title":"Liposomal amphotericin B treatment of Old World cutaneous and mucosal leishmaniasis: a literature review","volume":"182","author":"Mosimann","year":"2018","journal-title":"Acta Trop"},{"key":"10.1016\/j.annder.2026.103503_b0435","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1093\/jac\/dks275","article-title":"Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis","volume":"67","author":"Dorlo","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.annder.2026.103503_b0440","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taab065","article-title":"Efficacy and safety of pentamidine isethionate for tegumentary and visceral human leishmaniasis: a systematic review","volume":"28","author":"Piccica","year":"2021","journal-title":"J Travel Med"},{"key":"10.1016\/j.annder.2026.103503_b0445","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000018343","article-title":"Treatment of Old World cutaneous leishmaniasis by pentamidine isethionate. An open study of 11 patients","volume":"200","author":"Hellier","year":"2000","journal-title":"Dermatol Basel Switz"},{"key":"10.1016\/j.annder.2026.103503_b0450","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1046\/j.1365-4362.2002.01633.x","article-title":"Pentamidine, the drug of choice for the treatment of cutaneous leishmaniasis in Surinam","volume":"41","author":"Lai","year":"2002","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.annder.2026.103503_b0455","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/00034983.2001.11813645","article-title":"Influence of clinical presentation on the efficacy of a short course of pentamidine in the treatment of cutaneous leishmaniasis in French Guiana","volume":"95","author":"Nacher","year":"2001","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.annder.2026.103503_b0460","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.tmaid.2018.02.010","article-title":"Use of the intramuscular route to administer pentamidine isethionate in Leishmania guyanensis cutaneous leishmaniasis increases the risk of treatment failure","volume":"24","author":"Christen","year":"2018","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.annder.2026.103503_b0465","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1179\/136485906X105561","article-title":"Comparison between one and two injections of pentamidine isethionate, at 7 mg\/kg in each injection, in the treatment of cutaneous leishmaniasis in French Guiana","volume":"100","author":"Roussel","year":"2006","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.annder.2026.103503_b0470","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4269\/ajtmh.1990.42.43","article-title":"Placebo-controlled clinical trial of meglumine antimonate (glucantime) vs. localized controlled heat in the treatment of cutaneous leishmaniasis in Guatemala","volume":"42","author":"Navin","year":"1990","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.annder.2026.103503_b0475","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0002-9343(90)90292-L","article-title":"Efficacy of ketoconazole against Leishmania braziliensis panamensis cutaneous leishmaniasis","volume":"89","author":"Saenz","year":"1990","journal-title":"Am J Med"},{"key":"10.1016\/j.annder.2026.103503_b0480","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1056\/NEJMoa011882","article-title":"Fluconazole for the Treatment of Cutaneous Leishmaniasis Caused by Leishmania major","volume":"346","author":"Alrajhi","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annder.2026.103503_b0485","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jaad.2010.04.014","article-title":"Superior efficacy of oral fluconazole 400 mg daily versus oral fluconazole 200 mg daily in the treatment of cutaneous leishmania major infection: a randomized clinical trial","volume":"64","author":"Emad","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2026.103503_b0490","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006225","article-title":"Failure of fluconazole in treating cutaneous leishmaniasis caused by Leishmania guyanensis in the Brazilian Amazon: an open, nonrandomized phase 2 trial","volume":"12","author":"Francesconi","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.annder.2026.103503_b0495","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/cid\/ciw662","article-title":"Fluconazole in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania braziliensis\u202f: a randomized controlled trial","volume":"64","author":"Prates","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.annder.2026.103503_b0500","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/cid\/cir496","article-title":"High-dose oral fluconazole therapy effective for cutaneous leishmaniasis due to leishmania (Vianna) braziliensis","volume":"53","author":"Sousa","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.annder.2026.103503_b0505","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/bjd.18964","article-title":"American cutaneous leishmaniasis in French Guiana: a retrospective comparison between liposomal amphotericin B and meglumine antimoniate","volume":"183","author":"Senchyna","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2026.103503_b0510","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/cid\/civ416","article-title":"Treatment of disseminated leishmaniasis with liposomal amphotericin B","volume":"61","author":"Machado","year":"2015","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.annder.2026.103503_b0515","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006094","article-title":"Liposomal amphotericin B in travelers with cutaneous and muco-cutaneous leishmaniasis: not a panacea","volume":"11","author":"Guery","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.annder.2026.103503_b0520","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/tmi.13210","article-title":"American tegumentary leishmaniasis in Brazil: a critical review of the current therapeutic approach with systemic meglumine antimoniate and short-term possibilities for an alternative treatment","volume":"24","author":"Carvalho","year":"2019","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.annder.2026.103503_b0525","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1179\/136485906X118495","article-title":"Generic sodium stibogluconate is as safe and effective as branded meglumine antimoniate, for the treatment of tegumentary leishmaniasis in Isiboro Secure Park","volume":"100","author":"Berm\u00fadez","year":"2006","journal-title":"Bolivia Ann Trop Med Parasitol"},{"key":"10.1016\/j.annder.2026.103503_b0530","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1590\/S0365-05962011000600005","article-title":"A randomized clinical trial comparing meglumine antimoniate, pentamidine and amphotericin B for the treatment of cutaneous leishmaniasis by Leishmania guyanensis","volume":"86","author":"Neves","year":"2011","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.annder.2026.103503_b0535","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.actatropica.2011.02.007","article-title":"Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World","volume":"118","author":"Oliveira","year":"2011","journal-title":"Acta Trop"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963826000372?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963826000372?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T20:45:18Z","timestamp":1781124318000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963826000372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":107,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0151963826000372"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2026.103503","relation":{},"ISSN":["0151-9638"],"issn-type":[{"value":"0151-9638","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cutaneous leishmaniasis: 2026 guidelines for diagnosis and treatment","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2026.103503","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"103503"}}